What are the objectives of clinical trials of Spanish tuberculosis vaccine MTBVAC beginning in India
Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India.
- Assess the safety and efficacy of the Spanish tuberculosis vaccine MTBVAC in a population with a high burden of tuberculosis like India.
- Evaluate the immune response generated by the vaccine in participants.
- Determine the optimal dosing and vaccination schedule for the vaccine in the Indian population.
- Compare the performance of MTBVAC with existing tuberculosis vaccines to identify its potential advantages.
- Monitor any adverse reactions or side effects associated with the vaccine in the Indian demographic.
- Contribute to the global effort to develop improved tuberculosis vaccines that are more effective and accessible.
Answered
a year ago